BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to ...

BMO Capital analyst Ari Klein maintained a Buy rating on Equinix (EQIX – Research Report) today and set a price target of $1,045.00. The ...

In a report released today, Ari Klein from BMO Capital maintained a Buy rating on Digital Realty (DLR – Research Report), with a price target ...

BMO raised $618m on Tuesday in its first CMBS conduit deal to be backed by five-year loans this year, but was forced to widen ...

Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney Formation, arguing such a deal would boost scale and broaden investor appeal.

BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...

Bank stocks are sure to be long-term winners in Canada, but these three look ultra promising for investors.